Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives
- PMID: 32066632
- DOI: 10.1136/jmedgenet-2019-106346
Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives
Abstract
Background: Familial intestinal gastric cancer (FIGC) remains genetically unexplained and without testing/clinical criteria. Herein, we characterised the age of onset and disease spectrum of 50 FIGC families and searched for genetic causes potentially underlying a monogenic or an oligogenic/polygenic inheritance pattern.
Methods: Normal and tumour DNA from 50 FIGC probands were sequenced using Illumina custom panels on MiSeq, and their respective germline and somatic landscapes were compared with corresponding landscapes from sporadic intestinal gastric cancer (SIGC) and hereditary diffuse gastric cancer cohorts.
Results: The most prevalent phenotype in FIGC families was gastric cancer, detected in 138 of 208 patients (50 intestinal gastric cancer probands and 88 unknown gastric cancer histology relatives), followed by colorectal and breast cancers. After excluding benign and intronic variants lacking impact in splicing, 12 rare high-quality variants were found exclusively in 11 FIGC probands. Only two probands carried potentially deleterious variants, but lacked somatic second-hits, weakly supporting the monogenic hypothesis for FIGC. However, FIGC probands developed gastric cancer at least 10 years earlier and carried more TP53 germline common variants than SIGC (p=4.5E-03); FIGC and SIGC could be distinguished by specific germline and somatic variant profiles; there was an excess of FIGC tumours presenting microsatellite instability (38%); and FIGC tumours displayed significantly more somatic common variants than SIGC tumours (p=4.2E-06).
Conclusion: This study proposed the first data-driven testing criteria for FIGC families, and supported FIGC as a genetically determined, likely polygenic, gastric cancer-predisposing disease, with earlier onset and distinct from patients with SIGC at the germline and somatic levels.
Keywords: cancer: gastric; clinical genetics; diagnostics; evidence based practice; molecular genetics.
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes.Eur J Med Genet. 2022 Jan;65(1):104401. doi: 10.1016/j.ejmg.2021.104401. Epub 2021 Dec 3. Eur J Med Genet. 2022. PMID: 34871783 Review.
-
E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.Eur J Cancer. 2004 Aug;40(12):1897-903. doi: 10.1016/j.ejca.2004.04.027. Eur J Cancer. 2004. PMID: 15288293
-
Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria.J Med Genet. 2019 Dec;56(12):838-843. doi: 10.1136/jmedgenet-2019-105991. Epub 2019 Jul 11. J Med Genet. 2019. PMID: 31296550
-
Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.Gut. 2007 Jul;56(7):926-33. doi: 10.1136/gut.2006.114876. Epub 2007 Jan 31. Gut. 2007. PMID: 17267619 Free PMC article.
-
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer.Eur J Cancer. 2011 Mar;47(4):631-9. doi: 10.1016/j.ejca.2010.10.011. Epub 2010 Nov 22. Eur J Cancer. 2011. PMID: 21106365 Review.
Cited by
-
Risk of Esophageal and Gastric Cancer in Patients with Type 2 Diabetes Receiving Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A National Analysis.Cancers (Basel). 2024 Sep 22;16(18):3224. doi: 10.3390/cancers16183224. Cancers (Basel). 2024. PMID: 39335195 Free PMC article.
-
Hereditary Diffuse Gastric Cancer-Update Based on the Current Consort Recommendations.Curr Oncol. 2022 Mar 30;29(4):2454-2460. doi: 10.3390/curroncol29040199. Curr Oncol. 2022. PMID: 35448173 Free PMC article.
-
Gastric Cancer: A Practical Review on Management of Individuals with Hereditary or Familial Risk for Gastric Cancer.GE Port J Gastroenterol. 2022 Nov 18;30(4):253-266. doi: 10.1159/000527208. eCollection 2023 Aug. GE Port J Gastroenterol. 2022. PMID: 37767311 Free PMC article. Review.
-
Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience.Genes (Basel). 2023 May 13;14(5):1077. doi: 10.3390/genes14051077. Genes (Basel). 2023. PMID: 37239438 Free PMC article.
-
Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes.Pathologica. 2020 Sep;112(3):166-185. doi: 10.32074/1591-951X-166. Pathologica. 2020. PMID: 33179620 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous